Nanjing, China

Di Di

This inventor holds 1 USPTO granted patent. Top assignee: Nanjing University of Chinese Medicine. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Di Di. Retrieved from https://idiyas.com/inventor/di-di

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Di Di in Anti-Colon Cancer Research

Introduction

Di Di is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-cancer properties. His work focuses on creating innovative solutions to combat colon cancer, a prevalent health issue.

Latest Patents

Di Di holds a patent for a compound titled "(9beta-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity and derivative thereof." This invention reveals a (9β-H)-pimarane skeleton diterpenoid that exhibits anti-colon cancer activity. The patent also includes a preparation method and application of these compounds. Notably, the compounds have shown inhibition effects on colon cancer cells, with one derivative demonstrating remarkable anti-proliferation effects on two colon cancer cell lines, HT-29 and SW620. These effects surpass those of the positive drug 5-fluorouracil, indicating the potential for developing a new anti-colon cancer drug.

Career Highlights

Di Di is affiliated with Nanjing University of Chinese Medicine, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing cancer treatment. With a focus on creating effective therapeutic agents, Di Di continues to contribute to the advancement of medical science.

Collaborations

Di Di collaborates with esteemed colleagues, including Ming Zhao and Jinao Duan. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation.

Conclusion

Di Di's contributions to anti-colon cancer research exemplify the impact of innovative thinking in the medical field. His patented compounds hold promise for future cancer therapies, showcasing the importance of continued research and development in combating serious health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…